Literature DB >> 9196522

Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid.

V M Keatings1, D J Evans, B J O'Connor, P J Barnes.   

Abstract

BACKGROUND: Analysis of bronchoalveolar lavage fluid has improved our understanding of the pathogenesis of asthma. Safety issues and access to expert resources limit this techniques as a research tool. Induced sputum is a non-invasive method of collecting airway fluid which is applicable to subjects with a range of severity of airflow obstruction. The method of sputum collection and processing differs between groups. A study was undertaken to compare induced sputum with bronchoscopically collected fluid.
METHODS: Sixteen patients with mild stable asthma underwent both sputum induction and bronchoscopic examination with bronchial washings and bronchoalveolar lavage (BAL) in random order, with each procedure being separated by an interval of 12 days. Airway fluid was processed and stained for differential cell counting.
RESULTS: Induced sputum was relatively rich in neutrophils and eosinophils compared with bronchial washings and BAL fluid (mean (SE) 1.3 (0.4)%, 5.0 (2.7)%, and 36.4 (3.7)% neutrophils and 0.6 (0.1)%, 1.6 (0.6)%, and 3.3 (1.1)% eosinophils in BAL fluid, bronchial washings, and induced sputum, respectively). The proportions of cells obtained at sputum induction correlated with those in bronchial washings but not BAL fluid (r = 0.6 and 0.7 for neutrophils and eosinophils, respectively, p < 0.05). By contrast, induced sputum had a lower proportion of lymphocytes and macrophages than bronchial washings or BAL fluid, without any correlation.
CONCLUSION: Induced sputum is rich in neutrophils and eosinophils and poor in lymphocytes, suggesting an origin in the larger airways. Induced sputum adequately reflects the findings in fluid collected by direct bronchoscopy.

Entities:  

Mesh:

Year:  1997        PMID: 9196522      PMCID: PMC1758529          DOI: 10.1136/thx.52.4.372

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  13 in total

1.  Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects.

Authors:  J V Fahy; J Liu; H Wong; H A Boushey
Journal:  Am Rev Respir Dis       Date:  1993-05

2.  Influence of cardiac output on intrapulmonary shunt.

Authors:  J P Lynch; J G Mhyre; D R Dantzker
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-02

3.  Comparison of samples collected by sputum induction and bronchoscopy from asthmatic and healthy subjects.

Authors:  J V Fahy; H Wong; J Liu; H A Boushey
Journal:  Am J Respir Crit Care Med       Date:  1995-07       Impact factor: 21.405

4.  Prostaglandin I2 supports blood flow to hypoxic alveoli in anesthetized dogs.

Authors:  R S Sprague; A H Stephenson; A J Lonigro
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1984-05

5.  Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.

Authors:  J G De Monchy; H F Kauffman; P Venge; G H Koëter; H M Jansen; H J Sluiter; K De Vries
Journal:  Am Rev Respir Dis       Date:  1985-03

6.  Use of induced sputum cell counts to investigate airway inflammation in asthma.

Authors:  I Pin; P G Gibson; R Kolendowicz; A Girgis-Gabardo; J A Denburg; F E Hargreave; J Dolovich
Journal:  Thorax       Date:  1992-01       Impact factor: 9.139

7.  The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension.

Authors:  E K Weir; L J Rubin; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; C G Elliott; A P Fishman; R M Goldring; B M Groves
Journal:  Am Rev Respir Dis       Date:  1989-12

8.  High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.

Authors:  S Rich; B H Brundage
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

9.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391

10.  The effects of chronic bronchitis and chronic air-flow obstruction on lung cell populations recovered by bronchoalveolar lavage.

Authors:  T R Martin; G Raghu; R J Maunder; S C Springmeyer
Journal:  Am Rev Respir Dis       Date:  1985-08
View more
  15 in total

1.  Elevated levels of NO are localized to distal airways in asthma.

Authors:  John T Anderson; Meiqin Zeng; Qian Li; Ryan Stapley; Doyle Ray Moore; Balachandra Chenna; Naomi Fineberg; Jaroslaw Zmijewski; Isam-Eldin Eltoum; Gene P Siegal; Amit Gaggar; Stephen Barnes; Sadanandan E Velu; Victor J Thannickal; Edward Abraham; Rakesh P Patel; Jack R Lancaster; David D Chaplin; Mark T Dransfield; Jessy S Deshane
Journal:  Free Radic Biol Med       Date:  2011-03-16       Impact factor: 7.376

Review 2.  Human asthma phenotypes: from the clinic, to cytokines, and back again.

Authors:  Nirav R Bhakta; Prescott G Woodruff
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

3.  Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation.

Authors:  M Corradi; P Pignatti; P Manini; R Andreoli; M Goldoni; M Poppa; G Moscato; B Balbi; A Mutti
Journal:  Eur Respir J       Date:  2004-12       Impact factor: 16.671

4.  Effect of repeated sputum induction on cell counts in normal volunteers.

Authors:  J A Nightingale; D F Rogers; P J Barnes
Journal:  Thorax       Date:  1998-02       Impact factor: 9.139

5.  High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis.

Authors:  Rabindra Tirouvanziam; Carol K Conrad; Teodoro Bottiglieri; Leonore A Herzenberg; Richard B Moss; Leonard A Herzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-13       Impact factor: 11.205

6.  Failure of sputum eosinophilia after eotaxin inhalation in asthma.

Authors:  D Bumbacea; J Scheerens; B S Mann; R G Stirling; K F Chung
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

7.  Mucosal-associated invariant T cells and Vδ2+ γδ T cells in community acquired pneumonia: association of abundance in sputum with clinical severity and outcome.

Authors:  R F Hannaway; X Wang; M Schneider; S Slow; J Cowan; B Brockway; M R Schofield; X C Morgan; D R Murdoch; J E Ussher
Journal:  Clin Exp Immunol       Date:  2019-10-24       Impact factor: 4.330

8.  Clinical characteristics and long-term outcomes related to sputum eosinophilia in Korean asthmatics.

Authors:  Jae-Woo Jung; Sae-Hoon Kim; Jae-Woo Kwon; Tae-Wan Kim; Hye-Ryun Kang; Heung-Woo Park; Sun-Sin Kim; Yoon-Seok Chang; Sang-Heon Cho; Kyung-Up Min
Journal:  Asia Pac Allergy       Date:  2011-03-30

Review 9.  Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.

Authors:  Leena George; Christopher E Brightling
Journal:  Ther Adv Chronic Dis       Date:  2016-01       Impact factor: 5.091

10.  Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.

Authors:  Ulrich Baumann; Kerstin Göcke; Britta Gewecke; Joachim Freihorst; Bernd Ulrich von Specht
Journal:  Respir Res       Date:  2007-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.